FiercePharma2d
AZ, Daiichi's Enhertu nabs 7th FDA nod, including in 'HER2-ultralow' use, in breast cancer first
Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval | The FDA has cleared AstraZeneca and Daiichi Sankyo's ...
Hosted on MSN23d
Woman, 40, Shares Final Goodbye on Social Media After Being Denied Life-Saving Cancer Treatment
It is particularly hard to treat, and has limited treatment options. Enhertu has been shown to improve the life expectancy of people with this disease, according to Health. The treatment involves ...
Nasdaq3d
FDA Approves AstraZeneca And Daiichi Sankyo's ENHERTU For HER2-Low/Ultralow Breast Cancer
(AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive ...
Hosted on MSN6mon
A cancer drug could give me more time - but my life 'isn't worth the cost'
Called Enhertu, it is the first licensed targeted ... and has been shown to lengthen a patient’s life span for much longer than traditional treatments such as chemotherapy.